![](/img/cover-not-exists.png)
Phase I study of intravenous (IV) oxaliplatin and intraperitoneal (IP) docetaxel in recurrent ovarian and primary peritoneal cancer
Taylor, S.E., Li, R., Petschauer, J.S., Donovan, H.D., Zamboni, W.C., Edwards, R.P., Zorn, K.K.Volume:
137
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.01.370
Date:
April, 2015
File:
PDF, 49 KB
english, 2015